SCHEMBL5735182

SCHEMBL5735182

C=C1CC(C(N)=O)N(C(=O)Nc2ccc3c(c2)c2ccccc2n3CC)C1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.55
MAPT P10636 11/20 0.55
KDM4E B2RXH2 8/20 0.55
LMNA P02545 6/20 0.55
NPY5R Q15761 5/20 0.55
ALDH1A1 P00352 5/20 0.55
HPGD P15428 5/20 0.55
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
RAB9A P51151 3/20 0.55
NPC1 O15118 2/20 0.55
REV1 Q9UBZ9 1/20 0.55
CNR1 P21554 1/20 0.49
CNR2 P34972 1/20 0.49
GAA P10253 1/20 0.49
RORC P51449 2/20 0.48
HCRTR1 O43613 1/20 0.48
PAX8 Q06710 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4943227 0.89 RORC (0.54) NPSR1MAPTKDM4ELMNANPY5R
SCHEMBL4944102 0.86 MAPT (0.50) NPSR1MAPTKDM4ELMNANPY5R
SCHEMBL5738208 0.85 NPSR1 (0.52) NPSR1MAPTKDM4ELMNANPY5R
SCHEMBL4939071 0.83 MAPT (0.57) NPSR1MAPTKDM4ELMNANPY5R
SCHEMBL5735456 0.82 REV1 (0.62) NPSR1MAPTKDM4ELMNANPY5R
SCHEMBL4942276 0.81 NPSR1 (0.53) NPSR1MAPTKDM4ELMNANPY5R
SCHEMBL4940429 0.81 MAPT (0.51) NPSR1MAPTKDM4ELMNANPY5R
SCHEMBL7084978 0.81 MAPT (0.51) NPSR1MAPTKDM4ELMNANPY5R
SCHEMBL4945448 0.78 NPSR1 (0.50) NPSR1MAPTKDM4ELMNANPY5R
SCHEMBL4939900 0.77 NPY5R (0.52) NPSR1MAPTKDM4ELMNANPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268419-B1 PYRROLIDINE DERIVATIVES USEFUL AS BAX INHIBITORS APPLIED RESEARCH SYSTEMS (AN) 2006-06-21 EP disclosed
EP-1268418-B1 PHARMACEUTICALLY ACTIVE PYRROLIDINE DERIVATIVES AS BAX INHIBITORS APPLIED RESEARCH SYSTEMS (AN) 2006-06-14 EP disclosed